Depression News and Research

Latest Depression News and Research

People with recurrent depression, chronic stress have shorter telomeres in WBCs

People with recurrent depressions or those exposed to chronic stress exhibits shorter telomeres in white blood cells. This is shown by a research team at Umeå University in a coming issue of Biological Psychiatry.

9 Nov 2011

UCSB researchers study how genotypes can express themselves differently as a function of culture

Two psychologists at UC Santa Barbara have provided a new twist on the old adage that people are products of both nature and nurture, in introducing a framework for understanding how these influences interact.

9 Nov 2011

Insulin resistance associated with cortical atrophy and brain dysfunction

Many complications of diabetes, including kidney disease, foot problems and vision problems are generally well recognized. But the disease's impact on the brain is often overlooked.

9 Nov 2011

QRxPharma receives FDA written acceptance for review of MoxDuo IR NDA

QRxPharma Limited announced today it received written acceptance from the United States Food and Drug Administration (FDA) for review of the MoxDuo IR New Drug Application (NDA) filed earlier this year.

9 Nov 2011

Bisexual women more likely to suffer from depression, stress and tend to binge-drink

Bisexual women are more likely than their male counterparts to suffer from depression and stress and to binge-drink, according to a new national study led by George Mason University researcher Lisa Lindley.

9 Nov 2011

RNS system offers significant relief to patients with intractable seizures

Brain stimulation, already approved by the U.S. Food and Drug Administration for the treatment of Parkinson's disease and essential tremor, has now been shown to offer significant relief to patients with intractable seizures for whom drugs and other treatments have not worked.

9 Nov 2011

Higher protein load in critical brain regions linked to severe depression in late life

Depression is one of the most common mental disorders in the elderly, but little is known about the underlying biology of its development in older adults.

8 Nov 2011

Stem cell therapy for Parkinson’s

U.S. researchers have finally found a way to overcome difficulties in coaxing human embryonic stem cells to become the neurons killed by Parkinson's disease.

8 Nov 2011

Study looks at influence of father's depression on his children

There have been numerous studies that looked at the effect of mother's depression upon her children. But there have been no studies that explore the influence a father's depression on his children.

8 Nov 2011

QRxPharma receives date for US pain drug launch, pending approval

Australian pain-relief drug developer QRxPharma (QRX) has announced today that they have received from the US Food & Drug Adminstration.

8 Nov 2011

Top-line results from AstraZeneca and Targacept's TC-5214 Phase 3 studies on MDD

AstraZeneca and Targacept, Inc. today announced top-line results from the first of four RENAISSANCE Phase 3 studies investigating the efficacy and tolerability of TC-5214 as an adjunct therapy to an antidepressant in patients with major depressive disorder (MDD) who do not respond adequately to initial antidepressant treatment.

8 Nov 2011

New study questions effectiveness of current exercise referral schemes

Research commissioned by the NIHR Health Technology Assessment programme and carried out by research teams from the Peninsula College of Medicine and Dentistry (PCMD) and the Universities of Exeter (Sport and Health Sciences) and Brunel (Health Economics Research Group), has called into question the effectiveness of exercise referral schemes as they are delivered at present.

7 Nov 2011

Vertex announces positive interim data from INCIVEK Phase 2 combination trial on HIV, HCV

Vertex Pharmaceuticals Incorporated today announced positive interim results from an ongoing Phase 2 study designed to evaluate the safety and tolerability of INCIVEK (telaprevir) tablets in combination with pegylated-interferon and ribavirin in people who are co-infected with chronic genotype 1 hepatitis C (HCV) and human immunodeficiency virus.

7 Nov 2011

Earthquakes devastating in more ways than one: Review

According to a new study published Thursday in the Lancet earthquakes can be devastating during and after they have come and gone.

6 Nov 2011

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.

5 Nov 2011

Rexahn announces results from Serdaxin Phase IIb trial on major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced results from its Phase IIb clinical trial of Serdaxin in major depressive disorder.

5 Nov 2011

Psychotherapy could have diverse cerebral effects depending on certain genes

Problems like anxiety and depression are caused by psychological and environmental factors, and are known to be influenced by genetic proclivities. However, it is still not clear how each factor affects the brain's functions to induce anxious and depressive symptoms.

4 Nov 2011

Vanda third quarter total revenues increase to $8.0 million

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the third quarter and nine months ended September 30, 2011.

4 Nov 2011

Women and men ages 45 to 64 more likely to be hospitalized for knee replacement surgery

Women and men ages 45 to 64 were 2.5 times more likely to be hospitalized for knee replacement surgery in 2009 than in 1997, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

4 Nov 2011

Cerebellum contributes to creation of cognitive map in the hippocampus

The cerebellum is far more intensively involved in helping us navigate than previously thought. To move and learn effectively in spatial environments our brain, and particularly our hippocampus, creates a "cognitive" map of the environment. The cerebellum contributes to the creation of this map through altering the chemical communication between its neurones. If this ability is inactivated, the brain is no longer able to to create an effective spatial representation and thus navigation in an environment becomes impaired.

4 Nov 2011

Depression News and Research

Latest Depression News and Research

People with recurrent depression, chronic stress have shorter telomeres in WBCs

UCSB researchers study how genotypes can express themselves differently as a function of culture

Insulin resistance associated with cortical atrophy and brain dysfunction

QRxPharma receives FDA written acceptance for review of MoxDuo IR NDA

Bisexual women more likely to suffer from depression, stress and tend to binge-drink

RNS system offers significant relief to patients with intractable seizures

Higher protein load in critical brain regions linked to severe depression in late life

Stem cell therapy for Parkinson’s

Study looks at influence of father's depression on his children

QRxPharma receives date for US pain drug launch, pending approval

Top-line results from AstraZeneca and Targacept's TC-5214 Phase 3 studies on MDD

New study questions effectiveness of current exercise referral schemes

Vertex announces positive interim data from INCIVEK Phase 2 combination trial on HIV, HCV

Earthquakes devastating in more ways than one: Review

Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting

Rexahn announces results from Serdaxin Phase IIb trial on major depressive disorder

Psychotherapy could have diverse cerebral effects depending on certain genes

Vanda third quarter total revenues increase to $8.0 million

Women and men ages 45 to 64 more likely to be hospitalized for knee replacement surgery

Cerebellum contributes to creation of cognitive map in the hippocampus

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Depression News and Research

Latest Depression News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in